-
Chadda and Associates explored the hypothesis that noninvasive positive-pressure ventilation (NPPV) would unload the respiratory muscles and improve cardiac and hemodynamic function more effectively than continuous positive airway pressure (CPAP).
-
Many people experience the winter-time blues. Some people may feel down, have less energy, put on a few pounds, or have difficulty getting out of bed in the mornings during the dark, short days of winter.
-
New FDA Approvals
-
APhA awarded contract to establish Support Center; Wyeth stops producing two vaccines; Pharmacist participation in rounds cuts errors; Warnings strengthened on three medications; Certain medication errors more likely to be harmful.
-
As expected, the U.S. Food and Drug Administration (FDA) has given loratadine (Claritin) over-the-counter (OTC) status. Loratadine, the only nonsedating antihistamine available OTC, is approved for seasonal allergic rhinitis.
-
The cost of prescription drug coverage is expected to continue to increase at a rate of nearly 20% in 2003, according to a report released in late November.
-
-
Fondaparinux sodium (Arixtra) is the first of a new class of synthetic antithrombotic agents, known as the selective Factor-Xa inhibitors.
-
An investigational vaccine has reduced the incidence of both human papillomavirus type 16 (HPV-16) infection and HPV-16-related cervical intraepithelial neoplasia (pre-cancer of the cervix), according to research published in the Nov. 21, 2002, issue of the New England Journal of Medicine.
-
With a new year unfolding, Drug Utilization Review (DUR) takes this opportunity to look ahead at pharmacy practice, regulation, and the continued battle for pharmacists to receive provider status.